-
Plasma cell exocystiation is a potential glioma minimally invasive diagnostic tool
Time of Update: 2020-06-01
Primary brain tumors are the most difficult tumors to be diagnosed with a physical biopsy Therefore, noninvasive diagnosis of glioma has important clinical significance Extracellular vesicles (EV) can
-
Characteristics of patients with long-term survival of recurrent glioma after bevalmono treatment
Time of Update: 2020-06-01
Background methodology the study retrieved 1,397 patients treated with Bev in adult adults treated with Bev at the University of California, Los Angeles (UCLA) and Kaiser Medical Facility (KPLA) fr
-
System review and meta-analysis of low-level glioma therapy
Time of Update: 2020-06-01
Study background low-level gliomas, WHO Grade I and II stage semenglioomas accounted for 17%-22% of primary intracranial tumors, and their survival depended on pathological type and molecular charac
-
Prevention and control of cerebrospinal fluid leakage after surgery on the soles of the nose under the endoscope
Time of Update: 2020-06-01
In recent years, endoscopic endonasal surgery has been widely used to remove craniofacial tumors, but postoperative cerebrospinal fluid leakage (CSF leak) has caused great confusion among surgeons The
-
The role of FGFR3-TACC3 fusion gene in tumor metabolism
Time of Update: 2020-06-01
Chromosomal translocation leads to gene fusion is a common DNA abnormality in tumors and a target for targeted treatment Previous studies have found that 3% of glioblastomas contain FGFR3-TACC3 (F3-T3
-
Factors associated with poor prognosis of IDH wild gliomas
Time of Update: 2020-06-01
In 2016, WHO classified central nervous system tumors molecularly, classifying low-grade glioma (LGG) into IDH mutation and IDH wild type according to the mutation state of isocitric acid dehydrogenas
-
Transcriptionology of recurrent meningiomas
Time of Update: 2020-06-01
Meningioma is a common primary tumor in the intracranial and vertebral tubes, 80% is benign, the prognosis of the full surgical excision is good, but 20% of meningiomas recur, need re-surgery or radia
-
PET-CT detection 11C-methionine intake can determine the level of glioma
Time of Update: 2020-06-01
Background gliomas have been used in tumor tracing because they ingest edged 1 1 C-methionine ( 1 1 C-MET) higher than normal brain tissue 1 1 C-MET ingestion process is mainly done by sodium ion no
-
Diagnosis and treatment of lymphoma of the primary central nervous system
Time of Update: 2020-06-01
Primary central nervous system (CNS) lymphoma refers to the absence of systemic lymphoma, the pervasive large B-cell lymph nodes of the brain, eyes, soft meninges or spinal cord, malignant non-Hodgkin
-
Surgical techniques and efficacy of sudden-grinding of the post-bed by the nose endoscopic epidural
Time of Update: 2020-06-01
In recent years, surgery to remove a tumour from the bottom of the skull has been extensive under the endoscopic endonasal approach, EEA, while EEA has been able to provide a wider surgical field of v
-
Application of circular cerebral cortex electrodes in wake-up anaesthetic open cranial surgery
Time of Update: 2020-06-01
Background about 40%-70% of glioma patients have a brain tumor-related seizure (brain tumor-related epilepsy, BTRE) accurate location of eclampsia during surgery often relies on high-density cerebra
-
5-ALA fluorescence combined with progenitor IX (PpIX) quantitative analysis can improve LGG surgery results
Time of Update: 2020-06-01
Surgical excision is the main method for treating diffuse immersion low-level glioma (LGG) The patient's survival prognosis depends primarily on the accuracy and scope of tumor removal 5-aminoacetyl a
-
GBM and SVZ regions are independent factors in patient survival decline
Time of Update: 2020-06-01
The subvention of the ventricle (SVZ) is a concentrated area of neural stem cells glioblastoma (GBM) and SVZ region and tumor removal when the open ventricle was associated with tumor soft meninges s
-
GDC-0068 Target treatment PIK3CA mutant breast cancer brain metastasis
Time of Update: 2020-06-01
Brain metastasis is the most common malignant secondary brain tumor in adults, and the overall survival rate of patients is very low Breast cancer brain metastases (breast cancer brain metastases, BCB
-
Immune mechanism for the treatment of GBM with PD-1 inhibitors
Time of Update: 2020-06-01
Glioblastoma (GBM) is a common primary malignant brain tumor in adults, with an average survival of 16 months to 20 months after standard treatment A recent clinical trial of a recurrent GBM metastasi
-
Recurrent high-level meningioma optional intraradiator as an auxiliary treatment
Time of Update: 2020-06-01
Atypical meningioma (WHO class II) and malignant meningioma (WHO Class III) have high recurrence rates and limited treatment after recurrence It can be surgically removed again, but it is difficult to
-
Central hub of fiber connection in the central front-back-abdominal fiber junction
Time of Update: 2020-06-01
The central front alcopic front alcopic fiber junction area (VPFIA) is an important white matter structure on the central front venteth side associated with language, movement, and advanced cognitive
-
Advances in the study of adult diffuse glioma
Time of Update: 2020-06-01
Around 100,000 people worldwide are diagnosed with diffuse glioma each year; The most deadly glioblastomas accounted for 70-75% of diffuse gliomas, with a median lifetime of 14-17 months In 2007, WHO
-
IDH Wild GBM patients trial Nomotto prediction survival
Time of Update: 2020-06-01
With the in-depth study of the molecular biology characteristics of glioblastoma (GBM), the prediction of patient's survival is no longer a general "14 to 16 months", but should be based on the actual
-
IDH1 mutant glioma cells are less sensitive and invasive to radiotherapy
Time of Update: 2020-06-01
The mutation of isocric acid dehydrogenase 1 (IDH1) was associated with lower invasiveness of diffuse gliomas, increased radiotherapy sensitivity and extended overall survival Jacqueline Kessler, of t